Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study)

INTRODUCTION: Psoriasis is a chronic inflammatory skin disease that negatively impacts the quality of life of patients and their families. However, the most commonly used decision-making tools in psoriasis, Psoriasis Area and Severity Index (PASI), Physician Global Assessment (PGA) and Dermatology L...

Descripción completa

Detalles Bibliográficos
Autores principales: Augustin, Matthias, Sommer, Rachel, Daudén, Esteban, Laws, Philip, de Jong, Elke, Fabbrocini, Gabriella, Naldi, Luigi, Navarini, Alexander, Lambert, Jo, Reguiai, Ziad, Gerdes, Sascha, Massana, Eric, Obis, Teresa, Kasujee, Ismail, Mrowietz, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Patient-Centred Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933754/
https://www.ncbi.nlm.nih.gov/pubmed/36792337
http://dx.doi.org/10.1136/bmjopen-2021-060536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933754/
https://www.ncbi.nlm.nih.gov/pubmed/36792337
http://dx.doi.org/10.1136/bmjopen-2021-060536

Ejemplares similares